Bowel (colorectal) cancer, Melanoma, Skin cancer
Results
Phase 2
This study was to find out how small doses of bortezomib (Velcade) and the epilepsy drug sodium valproate worked in people with melanoma or bowel cancer.
Recruitment start: 21 August 2009
Recruitment end: 9 December 2011
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Prof Mark Middleton
Experimental Cancer Medicine Centre (ECMC)
Oxford Cancer Research Centre
Oxford Radcliffe Hospitals NHS Trust
Last reviewed: 28 Apr 2014
CRUK internal database number: 4453